DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

Novartis (NYSE: NVS)



company name or ticker
Company Photos
(Click to zoom)

Are Biosimilars the Next Big Thing in Biotech?

Biosimilars could soon become a major force in biotech as multiple top-selling biologics lose patent protection. So are biosimilars the next big thing in biotech, or are they overhyped?

Teva-Active Biotech Start Phase II on MS Drug - Analyst Blog

Novartis (NVS) Beats on Earnings in Q1, View Reiterated - Analyst Blog

Novartis (NVS) Beats on Earnings in Q1, View Reiterated - Analyst Blog

Novartis AG (NVS) Earnings Report: Q1 2015 Conference Call Transcript

Novartis's (NVS) CEO Joe Jimenez on Q1 2015 Results - Earnings Call Transcript

Amgen Reports An Upbeat Q1 Earnings

Novartis (NVS) Beats on Earnings & Revenues - Tale of the Tape

Novartis Posts Higher Q1 Profit

Amgen's Q1 Earnings Paints An Overall Positive Image To Investors

Amgen Beats on Q1 Earnings & Revenues, Ups Earnings View - Analyst Blog

See More Articles...